All Activities
Choose from the criteria below to find an activity that fits you best.
Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information ►
Featured Activity
Contemporary Evaluation and Management of Lung Cancer Targeted Therapies
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
SHOW SEARCH
![]() |
![]() |
![]() |
|
SIDP Members login to SIDP to verify your membership, then follow the members only link to receive discounts ![]() |
![]() |
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) |
Ryan Shields and Erin McCreary discuss notable infectious diseases publications
from the first half of 2020.
Papers discussed:
The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:
Erin K. McCreary, PharmD, BCPS, BCIDP
Antimicrobial Stewardship/Infectious Diseases Clinical Pharmacist
University of Pittsburgh Medical Center
Pittsburgh, PA
Ryan K. Shields, PharmD, MS
Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, PA
Release Date: September 4, 2020
Expiration Date: September 4, 2023
This activity is jointly provided by ProCE, Inc. and the Society of
Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal
Activity Number 0221-9999-20-357-H01-P has been assigned to this home study, knowledge-based
activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that
recognize ACPE providers. Completion of the evaluation and the post-test with a score
of 70% or higher are required to receive pharmacy CE credit. No partial credit will
be given. Statements of completion will be issued online at www.ProCE.com, and proof
of completion will be posted in NABP CPE Monitor profiles.
The Society of Infectious Diseases Pharmacists (SIDP) is accredited
by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious
diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online
upon successful completion of a post-test and online evaluation. The post-test must
be successfully completed in only one attempt. No partial credit will be given. BCIDP
accreditation begins 09/04/2020 for this activity and is available for one year from
this date.
Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), American College of Clinical Pharmacy (ACCP) and/or the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. McCreary has no relevant commercial or financial relationships to disclose. Dr. Shields has served as a consultant for Allergan, Entasis, Merck, Shionogi, and Summit; has served as a speaker for Menarini and Pfizer; has received research funds as an Investigator for Allergan, Merck, Shionogi, Tetraphase, and Venatorx.
This activity is provided by ProCE, Inc. and SIDP.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.